USPTO 2015–2025 USPTO PatentsView Foreign Corporation

UCL Business Ltd

USPTO PatentsView assignee record - 125 granted patents across 68 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

125

Total patents granted

CPC technology areas

17.2

Avg claims per patent

+2925%

5-year filing velocity

The verdict

UCL holds 125 US patents across 68 technology areas, rank #3,051 of 50,000 tracked assignees.

#3,051
of 50,000 US assignees by volume: Top 4%
by Innovation Score (60.0/100): 17.2
avg claims per patent: +2925%
filing velocity, last 5 yrs

Portfolio overview

UCL Business Ltd has been granted 125 US utility patents between 2018 and 2025, placing UCL Business Ltd at rank #3,051 across all assignees tracked by PlainPatent. This portfolio spans 68 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.2 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, UCL Business Ltd is one of the broader-portfolio assignees in the PatentsView dataset. By volume, UCL sits between Singapore Health Services PTE. Ltd. (125 patents, rank #3,047) and ASM Technology Singapore PTE Ltd (124 patents, rank #3,055) - the closest US assignees by grant volume. The composite Innovation Score of 60.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 121 grants, compared with 4 in the 2015–2019 window, a +2925% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. UCL Business Ltd's 17.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 68 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark UCL Business Ltd against peers pursuing similar technology classes.

Singapore Health…

125
SKC

125
Simplisafe

125
Stichting IMEC Ne…

125
Université Laval

125
V-nova Internatio…

125
Wm Wrigley Jr

125
UCL Business ◀

125
ASM Technology Si…

124

What this shows UCL holds 125 patents at rank #3,051, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near UCL

By rank, the assignees closest to #3,051 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in UCL's primary technology class.

UCL's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

60 Top 4% higher than 96% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

UCL Business Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	0.8%
2019	3	2.4%
2020	29	23.2%
2021	15	12.0%
2022	14	11.2%
2023	20	16.0%
2024	22	17.6%
2025	21	16.8%

Which technologies does UCL Business Ltd patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 72

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 56

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 44

C07K - PEPTIDES 42

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 18

C12Y - ENZYMES 14

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 11

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 10

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 7

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 7

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 5

C07D - HETEROCYCLIC COMPOUNDS 5

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 4

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 3

Top 15 of 68 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#3,051

Across all tracked assignees

Innovation Score

60.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does UCL Business Ltd hold?

UCL Business Ltd holds 125 US granted patents filed between 2018 and 2025, spanning 68 technology areas.

What is UCL Business Ltd's Innovation Score?

UCL Business Ltd has an Innovation Score of 60.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does UCL Business Ltd focus on?

UCL Business Ltd's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 72 patents. The company has filed patents in 68 CPC subclasses total.

Is UCL Business Ltd's patent filing rate increasing or decreasing?

UCL Business Ltd's recent filing velocity is +2925% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for UCL Business Ltd's patents?

UCL Business Ltd's patents average 17.2 claims each. This falls within the standard range, providing solid legal coverage.

How is the UCL Business Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

UCL's 125 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - UCL ranks #3,051 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.